Why the study?
An overview of available risk prediction models for CVDs, diabetes, and hypertension was needed to compare their effectiveness in identifying individuals at risk of developing these diseases.
Do specific risk prediction models improve the recognition of healthy adults at risk for cardiovascular diseases, diabetes, and hypertension compared to standard models?
Comparison
Risk prediction models for CVDs, diabetes, and hypertension compared with each other
Design
Umbrella systematic review
Authors
Loading...
Supports ABI-augmented Framingham or QRISK for CVD risk assessment; confirms these as standards while underscoring need for external validation over new models.
Do specific risk prediction models improve the recognition of healthy adults at risk for cardiovascular diseases, diabetes, and hypertension compared to standard models?
The Framingham score (alone or with Ankle-Brachial Index) and QRISK score remain the gold standards for CVD risk prediction, highlighting the need for external validation rather than new score development.
Lucaroni et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: